JP2025508406A5 - - Google Patents
Info
- Publication number
- JP2025508406A5 JP2025508406A5 JP2024548386A JP2024548386A JP2025508406A5 JP 2025508406 A5 JP2025508406 A5 JP 2025508406A5 JP 2024548386 A JP2024548386 A JP 2024548386A JP 2024548386 A JP2024548386 A JP 2024548386A JP 2025508406 A5 JP2025508406 A5 JP 2025508406A5
- Authority
- JP
- Japan
- Prior art keywords
- treatment
- compound
- antidepressant
- necessary
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263310581P | 2022-02-16 | 2022-02-16 | |
| US63/310,581 | 2022-02-16 | ||
| US202263337828P | 2022-05-03 | 2022-05-03 | |
| US63/337,828 | 2022-05-03 | ||
| US202363482200P | 2023-01-30 | 2023-01-30 | |
| US63/482,200 | 2023-01-30 | ||
| PCT/US2023/013098 WO2023158668A1 (en) | 2022-02-16 | 2023-02-15 | Neuroactive steroids for treatment of cns-related disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025508406A JP2025508406A (ja) | 2025-03-26 |
| JP2025508406A5 true JP2025508406A5 (cg-RX-API-DMAC7.html) | 2026-02-25 |
Family
ID=85569830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024548386A Pending JP2025508406A (ja) | 2022-02-16 | 2023-02-15 | Cns関連障害を処置するための神経活性ステロイド |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250295674A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4479032A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025508406A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240148425A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119072304A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023220976A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3252357A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL315023A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024009974A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202341995A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023158668A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS62761B1 (sr) | 2012-08-21 | 2022-01-31 | Sage Therapeutics Inc | Alopregnanolon za lečenje refraktornog epileptičkog statusa |
| SMT202100509T1 (it) | 2013-04-17 | 2021-11-12 | Sage Therapeutics Inc | Steroide di c21-n-pirazolile 19-nor c3,3-disostituito per l'uso in terapia |
| US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| WO2018013613A1 (en) | 2016-07-11 | 2018-01-18 | Sage Therapeutics, Inc. | C17, c20, and c21 substituted neuroactive steroids and their methods of use |
| TW202604538A (zh) | 2016-08-23 | 2026-02-01 | 美商賽吉醫療公司 | 結晶19-去甲c3,3-二取代之c21-n-吡唑類固醇 |
| US20200291059A1 (en) | 2017-12-08 | 2020-09-17 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| MX2023012727A (es) * | 2021-04-29 | 2023-11-08 | Sage Therapeutics Inc | Esteroide c21 -n-pirazolilo disubstituido 19-nor c3,3 para uso en el tratamiento de principales trastorno depresivo y depresion posparto. |
| CN117442618B (zh) * | 2023-10-23 | 2025-11-14 | 国科大杭州高等研究院 | 化合物ly2940094在制备治疗中枢神经系统脱髓鞘疾病药物中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SMT202100509T1 (it) | 2013-04-17 | 2021-11-12 | Sage Therapeutics Inc | Steroide di c21-n-pirazolile 19-nor c3,3-disostituito per l'uso in terapia |
| TW202604538A (zh) | 2016-08-23 | 2026-02-01 | 美商賽吉醫療公司 | 結晶19-去甲c3,3-二取代之c21-n-吡唑類固醇 |
| US20200291059A1 (en) | 2017-12-08 | 2020-09-17 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| WO2019241442A1 (en) * | 2018-06-12 | 2019-12-19 | Sage Therapeutics, Inc. | A 19-nor c3,3-disubstituted c21 -n-pyrazolyl steroid and methods of use thereof |
| CN111454318A (zh) * | 2019-01-20 | 2020-07-28 | 浙江易众化工有限公司 | 抗抑郁药物sage-217的晶型及其制备方法 |
| CA3187178A1 (en) | 2020-07-20 | 2022-01-27 | Sage Therapeutics, Inc. | Formulations of 19-nor c3,3- disubstituted c21-n-pyrazolyl steroid and methods of use thereof |
-
2023
- 2023-02-15 JP JP2024548386A patent/JP2025508406A/ja active Pending
- 2023-02-15 AU AU2023220976A patent/AU2023220976A1/en active Pending
- 2023-02-15 WO PCT/US2023/013098 patent/WO2023158668A1/en not_active Ceased
- 2023-02-15 CN CN202380033285.6A patent/CN119072304A/zh active Pending
- 2023-02-15 KR KR1020247030934A patent/KR20240148425A/ko active Pending
- 2023-02-15 IL IL315023A patent/IL315023A/en unknown
- 2023-02-15 EP EP23710570.5A patent/EP4479032A1/en active Pending
- 2023-02-15 US US18/839,147 patent/US20250295674A1/en active Pending
- 2023-02-15 CA CA3252357A patent/CA3252357A1/en active Pending
- 2023-02-15 TW TW112105363A patent/TW202341995A/zh unknown
- 2023-02-15 MX MX2024009974A patent/MX2024009974A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6406713B2 (ja) | 低用量薬剤によるうつ病および他の疾患の処置 | |
| JP2009511618A (ja) | 中度から重度のむずむず脚症候群(rls)を治療するためのプラミペキソールの使用 | |
| JP7265990B2 (ja) | 神経変性疾患あるいは認知機能障害の予防または治療剤としてのr-ケタミンおよびその誘導体 | |
| JP2023100904A5 (cg-RX-API-DMAC7.html) | ||
| JP2006509751A5 (cg-RX-API-DMAC7.html) | ||
| JPH08208471A (ja) | 薬物反応の増強作用 | |
| JP2009538331A (ja) | 抑うつ障害のための治療 | |
| CN1308533A (zh) | 具有抗抑郁效果的药物 | |
| JP2023143940A5 (cg-RX-API-DMAC7.html) | ||
| JP2021511365A5 (cg-RX-API-DMAC7.html) | ||
| JP2022519721A5 (cg-RX-API-DMAC7.html) | ||
| JP2022506113A5 (cg-RX-API-DMAC7.html) | ||
| Goldberg | Antidepressant use in the elderly: current status of nefazodone, venlafaxine and moclobemide | |
| JP2006506461A (ja) | ミルナシプランのパルス型放出組成物 | |
| CN105848655B (zh) | 用于注意力和认知障碍的、以及用于与神经变性障碍相关联的痴呆的新疗法 | |
| JP2025508051A5 (cg-RX-API-DMAC7.html) | ||
| EP2089022A2 (en) | Composition containing a mixture of antidepressants for treating premature ejaculation | |
| JP2021530568A5 (cg-RX-API-DMAC7.html) | ||
| WO2023112024A1 (en) | Method of treating parkinson's disease | |
| EA003546B1 (ru) | Новые способы лечения нервных расстройств | |
| JP2022521208A5 (cg-RX-API-DMAC7.html) | ||
| CN1468094A (zh) | 含有依匹期汀及假麻黄碱的新药物组合物 | |
| JP2025500344A5 (cg-RX-API-DMAC7.html) | ||
| Pasternak | Does tramadol have a place in the dental armamentarium? An atypical opioid in dental practice from the pharmacological perspective–Part I. General tramadol administration | |
| CN113194950B (zh) | 早泄(pe)的治疗和预防 |